259 related articles for article (PubMed ID: 27613601)
1. Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening.
Kiessling MK; Schuierer S; Stertz S; Beibel M; Bergling S; Knehr J; Carbone W; de Vallière C; Tchinda J; Bouwmeester T; Seuwen K; Rogler G; Roma G
BMC Genomics; 2016 Sep; 17(1):723. PubMed ID: 27613601
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.
Song CQ; Li Y; Mou H; Moore J; Park A; Pomyen Y; Hough S; Kennedy Z; Fischer A; Yin H; Anderson DG; Conte D; Zender L; Wang XW; Thorgeirsson S; Weng Z; Xue W
Gastroenterology; 2017 Apr; 152(5):1161-1173.e1. PubMed ID: 27956228
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis.
Chen S; Sanjana NE; Zheng K; Shalem O; Lee K; Shi X; Scott DA; Song J; Pan JQ; Weissleder R; Lee H; Zhang F; Sharp PA
Cell; 2015 Mar; 160(6):1246-60. PubMed ID: 25748654
[TBL] [Abstract][Full Text] [Related]
4. Minimal genome-wide human CRISPR-Cas9 library.
Gonçalves E; Thomas M; Behan FM; Picco G; Pacini C; Allen F; Vinceti A; Sharma M; Jackson DA; Price S; Beaver CM; Dovey O; Parry-Smith D; Iorio F; Parts L; Yusa K; Garnett MJ
Genome Biol; 2021 Jan; 22(1):40. PubMed ID: 33478580
[TBL] [Abstract][Full Text] [Related]
5. Efficient gene knockout and genetic interaction screening using the in4mer CRISPR/Cas12a multiplex knockout platform.
Esmaeili Anvar N; Lin C; Ma X; Wilson LL; Steger R; Sangree AK; Colic M; Wang SH; Doench JG; Hart T
Nat Commun; 2024 Apr; 15(1):3577. PubMed ID: 38678031
[TBL] [Abstract][Full Text] [Related]
6. Analysis of CRISPR-Cas9 screens identifies genetic dependencies in melanoma.
Christodoulou E; Rashid M; Pacini C; Droop A; Robertson H; Groningen TV; Teunisse AFAS; Iorio F; Jochemsen AG; Adams DJ; Doorn RV
Pigment Cell Melanoma Res; 2021 Jan; 34(1):122-131. PubMed ID: 32767816
[TBL] [Abstract][Full Text] [Related]
7. A scalable platform for efficient CRISPR-Cas9 chemical-genetic screens of DNA damage-inducing compounds.
Lin K; Chang YC; Billmann M; Ward HN; Le K; Hassan AZ; Bhojoo U; Chan K; Costanzo M; Moffat J; Boone C; Bielinsky AK; Myers CL
Sci Rep; 2024 Jan; 14(1):2508. PubMed ID: 38291084
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide CRISPR/Cas9 screens reveal shared and cell-specific mechanisms of resistance to SHP2 inhibition.
Wei W; Geer MJ; Guo X; Dolgalev I; Sanjana NE; Neel BG
J Exp Med; 2023 May; 220(5):. PubMed ID: 36820830
[TBL] [Abstract][Full Text] [Related]
9. Project Score database: a resource for investigating cancer cell dependencies and prioritizing therapeutic targets.
Dwane L; Behan FM; Gonçalves E; Lightfoot H; Yang W; van der Meer D; Shepherd R; Pignatelli M; Iorio F; Garnett MJ
Nucleic Acids Res; 2021 Jan; 49(D1):D1365-D1372. PubMed ID: 33068406
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer.
Yu C; Luo D; Yu J; Zhang M; Zheng X; Xu G; Wang J; Wang H; Xu Y; Jiang K; Xu J; Ma X; Jing J; Shi H
Oncogene; 2022 Jan; 41(2):191-203. PubMed ID: 34718347
[TBL] [Abstract][Full Text] [Related]
11. CoRe: a robustly benchmarked R package for identifying core-fitness genes in genome-wide pooled CRISPR-Cas9 screens.
Vinceti A; Karakoc E; Pacini C; Perron U; De Lucia RR; Garnett MJ; Iorio F
BMC Genomics; 2021 Nov; 22(1):828. PubMed ID: 34789150
[TBL] [Abstract][Full Text] [Related]
12. Multiplex enCas12a screens detect functional buffering among paralogs otherwise masked in monogenic Cas9 knockout screens.
Dede M; McLaughlin M; Kim E; Hart T
Genome Biol; 2020 Oct; 21(1):262. PubMed ID: 33059726
[TBL] [Abstract][Full Text] [Related]
13. EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities.
Yedier-Bayram O; Gokbayrak B; Kayabolen A; Aksu AC; Cavga AD; Cingöz A; Kala EY; Karabiyik G; Günsay R; Esin B; Morova T; Uyulur F; Syed H; Philpott M; Cribbs AP; Kung SHY; Lack NA; Onder TT; Bagci-Onder T
Cell Death Dis; 2022 Aug; 13(8):710. PubMed ID: 35973998
[TBL] [Abstract][Full Text] [Related]
14. Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screens.
Gonçalves E; Segura-Cabrera A; Pacini C; Picco G; Behan FM; Jaaks P; Coker EA; van der Meer D; Barthorpe A; Lightfoot H; Mironenko T; Beck A; Richardson L; Yang W; Lleshi E; Hall J; Tolley C; Hall C; Mali I; Thomas F; Morris J; Leach AR; Lynch JT; Sidders B; Crafter C; Iorio F; Fawell S; Garnett MJ
Mol Syst Biol; 2020 Jul; 16(7):e9405. PubMed ID: 32627965
[TBL] [Abstract][Full Text] [Related]
15. Discovery of synthetic lethal and tumor suppressor paralog pairs in the human genome.
Parrish PCR; Thomas JD; Gabel AM; Kamlapurkar S; Bradley RK; Berger AH
Cell Rep; 2021 Aug; 36(9):109597. PubMed ID: 34469736
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide base editor screen identifies regulators of protein abundance in yeast.
Schubert OT; Bloom JS; Sadhu MJ; Kruglyak L
Elife; 2022 Nov; 11():. PubMed ID: 36326816
[TBL] [Abstract][Full Text] [Related]
17. Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells.
Jaiswal A; Peddinti G; Akimov Y; Wennerberg K; Kuznetsov S; Tang J; Aittokallio T
Genome Med; 2017 Jun; 9(1):51. PubMed ID: 28569207
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic targeting using magnetic nanoparticles for rapid characterization of cellular proliferation regulators.
Wang Z; Wang H; Lin S; Angers S; Sargent EH; Kelley SO
Sci Adv; 2024 May; 10(19):eadj1468. PubMed ID: 38718125
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritization.
Pacini C; Duncan E; Gonçalves E; Gilbert J; Bhosle S; Horswell S; Karakoc E; Lightfoot H; Curry E; Muyas F; Bouaboula M; Pedamallu CS; Cortes-Ciriano I; Behan FM; Zalmas LP; Barthorpe A; Francies H; Rowley S; Pollard J; Beltrao P; Parts L; Iorio F; Garnett MJ
Cancer Cell; 2024 Feb; 42(2):301-316.e9. PubMed ID: 38215750
[TBL] [Abstract][Full Text] [Related]
20. Whole-genome CRISPR screens to understand Apicomplexan-host interactions.
Hesping E; Boddey JA
Mol Microbiol; 2024 Apr; 121(4):717-726. PubMed ID: 38225194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
